164 related articles for article (PubMed ID: 2685984)
21. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
Volberding PA; Lagakos SW; Koch MA; Pettinelli C; Myers MW; Booth DK; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS
N Engl J Med; 1990 Apr; 322(14):941-9. PubMed ID: 1969115
[TBL] [Abstract][Full Text] [Related]
22. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group.
Spector SA; Gelber RD; McGrath N; Wara D; Barzilai A; Abrams E; Bryson YJ; Dankner WM; Livingston RA; Connor EM
N Engl J Med; 1994 Nov; 331(18):1181-7. PubMed ID: 7935655
[TBL] [Abstract][Full Text] [Related]
23. Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017).
Mulder JW; Cooper DA; Mathiesen L; Sandström E; Clumeck N; Gatell JM; French M; Donovan B; Gray F; Yeo JM
AIDS; 1994 Mar; 8(3):313-21. PubMed ID: 7913326
[TBL] [Abstract][Full Text] [Related]
24. Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study Group.
McKinney RE; Pizzo PA; Scott GB; Parks WP; Maha MA; Lehrman SN; Riggs M; Eddy J; Lane BA; Eppes SC
J Pediatr; 1990 Apr; 116(4):640-7. PubMed ID: 2181102
[TBL] [Abstract][Full Text] [Related]
25. The antiviral effect of zidovudine and ribavirin in clinical trials and the use of p24 antigen levels as a virologic marker.
Spector SA; Kennedy C; McCutchan JA; Bozzette SA; Straube RG; Connor JD; Richman DD
J Infect Dis; 1989 May; 159(5):822-8. PubMed ID: 2496173
[TBL] [Abstract][Full Text] [Related]
26. Didanosine compared with continuation of zidovudine in HIV-infected patients with signs of clinical deterioration while receiving zidovudine. A randomized, double-blind clinical trial. The Bristol-Myers Squibb AI454-010 Study Group.
Spruance SL; Pavia AT; Peterson D; Berry A; Pollard R; Patterson TF; Frank I; Remick SC; Thompson M; MacArthur RD; Morey GE; Ramirez-Ronda CH; Bernstein BM; Sweet DE; Crane L; Peterson EA; Pachucki CT; Green SL; Brand J; Rios A; Dunkle LM; Cross A; Brown MJ; Ingraham P; Gugliotti R; Schindzielorz AH; Smaldone L
Ann Intern Med; 1994 Mar; 120(5):360-8. PubMed ID: 7905722
[TBL] [Abstract][Full Text] [Related]
27. A pilot study of sequential therapy with zidovudine plus acyclovir, dideoxyinosine, and dideoxycytidine in patients with severe human immunodeficiency virus infection.
Nguyen BY; Shay LE; Wyvill KM; Pluda JM; Brawley O; Cohen RB; Whitcup SM; Venzon DJ; Broder S; Yarchoan R
J Infect Dis; 1993 Oct; 168(4):810-7. PubMed ID: 8397267
[TBL] [Abstract][Full Text] [Related]
28. [Decrease in human immunodeficiency virus antigen levels in the cerebrospinal fluid during zidovudine treatment in patients with AIDS].
de Gans J; Lange JM; Derix MM; de Wolf F; Ongerboer de Visser BW; Goudsmit J
Ned Tijdschr Geneeskd; 1988 Sep; 132(36):1656-60. PubMed ID: 3050555
[No Abstract] [Full Text] [Related]
29. Clinical trials of zidovudine in HIV infection.
Lancet; 1989 Aug; 2(8661):483-4. PubMed ID: 2570190
[No Abstract] [Full Text] [Related]
30. The predictive value of changes in serologic and cell markers of HIV activity for subsequent clinical outcome in patients with asymptomatic HIV disease treated with zidovudine.
Jacobson MA; De Gruttola V; Reddy M; Arduino JM; Strickland S; Reichman RC; Bartlett JA; Phair JP; Hirsch MS; Collier AC
AIDS; 1995 Jul; 9(7):727-34. PubMed ID: 7546418
[TBL] [Abstract][Full Text] [Related]
31. Zidovudine improves response to pneumococcal vaccine among persons with AIDS and AIDS-related complex.
Glaser JB; Volpe S; Aguirre A; Simpkins H; Schiffman G
J Infect Dis; 1991 Oct; 164(4):761-4. PubMed ID: 1894937
[TBL] [Abstract][Full Text] [Related]
32. Statistical methods for the analysis of HIV-1 core polypeptide antigen data in clinical studies.
Makuch RW; Parks WP
AIDS Res Hum Retroviruses; 1988 Aug; 4(4):305-16. PubMed ID: 3061416
[TBL] [Abstract][Full Text] [Related]
33. Natural history of advanced HIV disease in patients treated with zidovudine. The Zidovudine Epidemiology Study Group.
Moore RD; Keruly J; Richman DD; Creagh-Kirk T; Chaisson RE
AIDS; 1992 Jul; 6(7):671-7. PubMed ID: 1503686
[TBL] [Abstract][Full Text] [Related]
34. Influence on survival of p24 antigen levels in patients with AIDS or advanced AIDS related complex treated with zidovudine.
Zamora L; Gatell JM; Barrera JM; Ercilla G; Gil C; Buira E; Miro JM; Soriano E
Eur J Clin Microbiol Infect Dis; 1992 Dec; 11(12):1181-5. PubMed ID: 1291319
[TBL] [Abstract][Full Text] [Related]
35. Zidovudine treatment of patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex: long-term experience.
Smiley L
J Infect; 1989 Jan; 18 Suppl 1():77. PubMed ID: 2644363
[No Abstract] [Full Text] [Related]
36. Effect of stage of disease and drug dose on zidovudine susceptibilities of isolates of human immunodeficiency virus.
Richman DD; Grimes JM; Lagakos SW
J Acquir Immune Defic Syndr (1988); 1990; 3(8):743-6. PubMed ID: 2114476
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of erythrocytic adenosine deaminase following treatment of AIDS-related complex/AIDS patients with zidovudine.
Casoli C; Magnani G; Schianchi C; Barchi E; Bertazzoni U
AIDS; 1990 Aug; 4(8):799-802. PubMed ID: 2261134
[TBL] [Abstract][Full Text] [Related]
38. Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Concorde Coordinating Committee.
Lancet; 1994 Apr; 343(8902):871-81. PubMed ID: 7908356
[TBL] [Abstract][Full Text] [Related]
39. Effects of recombinant human granulocyte colony-stimulating factor on leucopenia in zidovudine-treated patients with AIDS and AIDS related complex, a phase I/II study.
van der Wouw PA; van Leeuwen R; van Oers RH; Lange JM; Danner SA
Br J Haematol; 1991 Jul; 78(3):319-24. PubMed ID: 1714756
[TBL] [Abstract][Full Text] [Related]
40. Didanosine therapy in patients intolerant of or failing zidovudine therapy.
Rathbun RC; Martin ES
Ann Pharmacother; 1992 Nov; 26(11):1347-51. PubMed ID: 1362093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
